GCDFP-15, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-GCDFP-15, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | GCDFP-15, Human |
| Clone | REAL828 |
| Host Species | Recombinant Human |
| Reactive Species | human |
| Isotype | n/a |
| Format | fluorescein (FITC) conjugate |
| Size | 200 µL |
| Concentration | n/a |
| Applications | MICS (MACSima Imaging Cyclic Staining), Immunohistochemistry, Immunofluorescence |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | GCDFP-15 Antibody, anti-human, FITC, REAdye_lease™. Clone REAL828 is an antibody fragment derived from the full GCDFP-15 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL828 recognizes the GCDFP-15 (gross cystic disease fluid protein 15), also known as Prolactin-inducible protein, extra-parotid glycoprotein (EP-GP), gp17 seminal actin-binding protein (SABP) or BRST2. In humans it is encoded by the PIP gene and is upregulated by prolactin and androgens and downregulated by estrogen. GCDFP-15 has various physiological functions and is used as a detection and diagnostic marker of breast cancer cells. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). |
| Immunogen | n/a |
| Other Names | PIP, GCDFP15, GPIP4, prolactin induced protein, extra-parotid glycoprotein (EP-GP), gp17 seminal actin-binding protein (SABP), BRST2 |
| Gene, Accession # | n/a |
| Catalog # | 130-126-210 |
| Price | $355 |
| Order / More Info | GCDFP-15, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Naderi, A. et al. (2012) Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer. Breast Cancer Res. 14 (4): R111. | Urbaniak, A. et al. (2018) Prolactin-induced protein (PIP)-characterization and role in breast cancer progression. Am. J. Cancer Res. 8 (11): 2150-2164. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies